Active Ingredient: LAROTRECTINIB SULFATE
Proprietary Name: VITRAKVI
Dosage Form; Route of Administration: SOLUTION; ORAL
Strength: EQ 20MG BASE/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N211710
Product Number: 001
Approval Date: Nov 26, 2018
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
